ACYCLOVIR

Trials studying ACYCLOVIR

• phase2A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovecrecruitingn=45
• phase2Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemiaactive not recruitingn=46
• phase2Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)recruitingn=60
• phase1A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degenerationrecruitingn=42
• phase3A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMTterminatedn=16
• phase3A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normallycompletedn=2,020
• phase3Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Canceractive not recruitingn=711
• phase2Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)active not recruitingn=187